Drugs for dementia to be initiated by HPFT for commissioned services only. Transfer of care can take place for patients whose care is commissioned by HVCCG and ENHCCG in line with the prescribing support summary document for the management of dementia drugs process
Guidelines for the Pharmacological Management of Dementia
NICE TA217 - Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease.
Note: Orodispersible tablets and oral solution formulations are significantly more costly than standard tablet formulations and use of such formulations should be regularly reviewed and switched to standard tablets where possible and clinically appropriate.
|Donepezil hydrochloride||5mg and 10mg tablets
5mg and 10mg orodispersible tablets
|Orodispersible tablets only to be prescribed in those who cannot swallow solid dose forms|
|Galantamine||8mg and 12mg tablets
8mg,16mg and 24mg MR (XL) capsules
4mg/ml oral solution
|MR/XL capsules more cost-effective than standard release tablets.
Oral solution only to be prescribed in those who cannot swallow solid dose forms.
Film coated tablets: 5mg, 10mg and 20mg tablets (including titration pack)
Orodispersible tablets: 10mg and 20mg
Titration pack containing 7 tablets of each strength 5mg, 10mg, 15mg, 20mg
Recommended as an option for managing Alzheimer's disease for people with:
Named patient request for all other dementias and BPSD.
Orodispersible tablets only to be prescribed in those who cannot swallow with solid dose forms.
|Rivastigmine||1.5mg, 3mg, 4.5mg, 6mg capsules
Patches 4.6mg/24 hours
2mg/ml oral solution
|Oral solution is significantly more expensive than capsules or transdermal patches and should only be used when these formulations are not appropriate.|
Continue to 2. Epilepsy and other seizures